Oral administration of cholera toxin B subunit conjugated to myelin basic protein protects against experimental autoimmune encephalomyelitis by inducing transforming growth factor-β-secreting cells and suppressing chemokine expression
Open Access
- 1 October 2000
- journal article
- research article
- Published by Oxford University Press (OUP) in International Immunology
- Vol. 12 (10) , 1449-1457
- https://doi.org/10.1093/intimm/12.10.1449
Abstract
The efficacy and mechanism of immunosuppression against experimental autoimmune encephalomyelitis (EAE) by oral low-dose administration of myelin basic protein (MBP) conjugated to cholera toxin B subunit (CTB) were investigated in Lewis rats immunized with MBP together with complete Freund's adjuvant 4 days before the start of treatment. Oral treatment with CTB–MBP conjugate gave almost complete protection against disease, an effect that was totally abrogated by including a low dose of cholera holotoxin (CT). The protection by CTB–MBP was associated with a dramatic reduction in the number of leukocytes staining for CD4, CD8, IL-2R or MHC class II in the spinal cord as examined by immunohistochemistry. The mRNA expressions of Th1 cytokines IFN-γ, IL-12 and tumor necrosis factor-α, as well as of chemokines monocyte chemotactic protein (MCP)-1 and RANTES in the spinal cord were also reduced by 76–94%, as assessed by in situ hybridization. In contrast, transforming growth factor (TGF)-β mRNA-expressing cells were strongly increased in the spinal cord from animals treated orally with the CTB–MBP conjugate. In the draining peripheral lymph nodes, the number of MBP-specific TGF-β mRNA-expressing cells was also increased, whereas there was a decrease in cells expressing Th1 or Th2 cytokine mRNA. Protection against EAE could be transferred by injection of cells from the mesenteric lymph nodes of animals fed with CTB–MBP into naive animals exposed to encephalitogenic T cells. The results indicate that the protective anti-inflammatory effect by oral treatment with CTB–MBP conjugate is, to a large extent, due to the induction of TGF-β-secreting suppressive-regulatory T cells and to local down-regulation of MCP-1 and RANTES in the spinal cord.Keywords
This publication has 37 references indexed in Scilit:
- Acute and relapsing experimental autoimmune encephalomyelitis are regulated by differential expression of the CC chemokines macrophage inflammatory protein-1α and monocyte chemotactic protein-1Journal of Neuroimmunology, 1998
- Identification of cell types producing RANTES, MIP-1α and MIP-1β in rat experimental autoimmune encephalomyelitis by in situ hybridizationJournal of Neuroimmunology, 1997
- Oral Tolerance: Immunologic Mechanisms and Treatment of Animal and Human Organ-Specific Autoimmune Diseases by Oral Administration of AutoantigensAnnual Review of Immunology, 1994
- Cholera toxin and cholera B subunit as oral—mucosal adjuvant and antigen vector systemsVaccine, 1993
- Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain.The Journal of Experimental Medicine, 1992
- Sensitive mRNA detection using unfixed tissue: combined radioactive and non-radioactive in situ hybridization histochemistryHistochemistry and Cell Biology, 1992
- Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic proteinCellular Immunology, 1988
- Actions of cholera toxin and the prevention and treatment of choleraNature, 1981
- The rapid isolation of clonable antigen‐specific T lymphocyte lines capable of mediating autoimmune encephalomyelitisEuropean Journal of Immunology, 1981
- Adoptive transfer of experimental allergic encephalomyelitis with activated spleen cells: Comparison of in vitro activation by concanavalin A and myelin basic proteinCellular Immunology, 1980